Legal & General Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $555K | Buy |
|
|||||
|
2025
Q2 | $957K | Buy |
|
|||||
|
2025
Q1 | $445K | Sell |
|
|||||
|
2024
Q4 | $374K | Buy |
|
|||||
|
2024
Q3 | $492K | Buy |
|
|||||
|
2024
Q2 | $266K | Buy |
|
|||||
|
2024
Q1 | $283K | Sell |
|
|||||
|
2023
Q4 | $154K | Hold |
|
|||||
|
2023
Q3 | $106K | Buy |
|
|||||
|
2023
Q2 | $167K | Sell |
|
|||||
|
2023
Q1 | $420K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $6K | Hold |
|
|||||
|
2021
Q4 | $11K | Sell |
|
|||||
|
2021
Q3 | $37K | Buy |
|
|||||
|
2021
Q2 | $32K | Sell |
|
|||||
|
2021
Q1 | $57K | Buy |
|
|||||
|
2020
Q4 | $1K | Buy |
|